ticlopidine-hydrochloride and Abbokinase Interactions

Interactions between ticlopidine-hydrochloride(ticlopidine) and Abbokinase (urokinase)

ticlopidine and urokinase (Moderate Drug-Drug)

MONITOR: Drugs that inhibit platelet function may increase the risk of bleeding when administered prior to, during, or after thrombolytic therapy.

MANAGEMENT: Careful monitoring for signs of bleeding, particularly at arterial puncture wounds, is recommended when thrombolytics are used concurrently or sequentially with antiplatelet agents.